Skip to main content

Peer Review reports

From: A randomized phase II study of S-1 monotherapy versus cisplatin with vinorelbine for completely resected stage II/IIIA non-small cell lung cancer: rationale and study protocol design for the LOGIK1702 study

Original Submission
22 May 2020 Submitted Original manuscript
24 Jun 2020 Reviewed Reviewer Report - Vittorio Gebbia
17 Aug 2020 Reviewed Reviewer Report
22 Sep 2020 Reviewed Reviewer Report - Research Square Reviewer 1
29 Oct 2020 Author responded Author comments - Tomoshi Tsuchiya
Resubmission - Version 2
29 Oct 2020 Submitted Manuscript version 2
3 Dec 2020 Reviewed Reviewer Report
19 Dec 2020 Author responded Author comments - Tomoshi Tsuchiya
Resubmission - Version 3
19 Dec 2020 Submitted Manuscript version 3
17 Jan 2021 Reviewed Reviewer Report
29 Jan 2021 Author responded Author comments - Tomoshi Tsuchiya
Resubmission - Version 4
29 Jan 2021 Submitted Manuscript version 4
6 Feb 2021 Author responded Author comments - Tomoshi Tsuchiya
Resubmission - Version 5
6 Feb 2021 Submitted Manuscript version 5
18 Feb 2021 Author responded Author comments - Tomoshi Tsuchiya
Resubmission - Version 6
18 Feb 2021 Submitted Manuscript version 6
Publishing
21 Feb 2021 Editorially accepted
8 Mar 2021 Article published 10.1186/s12885-021-07945-y

You can find further information about peer review here.

Back to article page